Company Name CoLucid Pharmaceuticals
Mailing Address P.O. Box 14401 Durham, NC 27709 USA
Company Description CoLucid Pharmaceuticals is an innovative biotechnology company focusing on therapies for central nervous system (CNS) disorders. CoLucid is leading a paradigm shift in migraine therapy with the clinical development of a first-in-class Neurally Acting Anti-Migraine Agent (NAAMA).
Proceeds Purposes Proceeds from the Series C will be used to fund the Company’s Phase 3 program for oral Lasmiditan, to include the first pivotal study, COL MIG-301 SAMURAI, for the acute treatment of migraine.